![A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma | NEJM A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1996/nejm_1996.335.issue-10/nejm199609053351003/production/images/img_medium/nejm199609053351003_t3.jpeg)
A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma | NEJM
![Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital | BMC Cardiovascular Disorders | Full Text Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2261-12-118/MediaObjects/12872_2012_Article_535_Fig1_HTML.jpg)
Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital | BMC Cardiovascular Disorders | Full Text
![Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave](https://www.medwave.cl/medios/medwave/SuplEpis3/6320/fg01_6320EN.jpg)
Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave
![Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1989/nejm_1989.320.issue-6/nejm198902093200604/20130822/images/img_medium/nejm198902093200604_t2.jpeg)
Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM
![Lifenox 60 mg/0.6 ml Low Molecular Weight Heparin Enoxaparin Sodium Injection IP at Rs 100/piece in Nabha Lifenox 60 mg/0.6 ml Low Molecular Weight Heparin Enoxaparin Sodium Injection IP at Rs 100/piece in Nabha](https://5.imimg.com/data5/SELLER/Default/2021/6/AN/RR/BR/6548395/lifenox-60-enoxaparin-injection-60mg-0-6ml-1000x1000.jpg)
Lifenox 60 mg/0.6 ml Low Molecular Weight Heparin Enoxaparin Sodium Injection IP at Rs 100/piece in Nabha
![Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1989/nejm_1989.320.issue-6/nejm198902093200604/20130822/images/img_medium/nejm198902093200604_t4.jpeg)
Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM
![Niedrig dosiertes Heparin: ("low-dose heparin"). Wirkungsweise und Indikationen : Bruhn, Hans D: Amazon.de: Bücher Niedrig dosiertes Heparin: ("low-dose heparin"). Wirkungsweise und Indikationen : Bruhn, Hans D: Amazon.de: Bücher](https://m.media-amazon.com/images/I/41vwwdl23nL._SX324_BO1,204,203,200_.jpg)